FBXW7-loss Sensitizes Cells to ATR Inhibition Through Induced Mitotic Catastrophe
Open Access
- 21 December 2023
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research Communications
- Vol. 3 (12) , 2596-2607
Abstract
FBXW7 is a commonly mutated tumor suppressor gene that functions to regulate numerous oncogenes involved in cell-cycle regulation. Genome-wide CRISPR fitness screens identified a signature of DNA repair and DNA damage response genes as required for the growth of FBXW7-knockout cells. Guided by these findings, we show that FBXW7-mutant cells have high levels of replication stress, which results in a genotype-specific vulnerability to inhibition of the ATR signaling pathway, as these mutant cells become heavily reliant on a robust S–G2 checkpoint. ATR inhibition induces an accelerated S-phase, leading to mitotic catastrophe and cell death caused by the high replication stress present in FBXW7−/− cells. In addition, we provide evidence in cell and organoid studies, and mining of publicly available high-throughput drug screening efforts, that this genotype-specific vulnerability extends to multiple types of cancer, providing a rational means of identifying responsive patients for targeted therapy. Significance: We have elucidated the synthetic lethal interactions between FBXW7 mutation and DNA damage response genes, and highlighted the potential of ATR inhibitors as targeted therapies for cancers harboring FBXW7 alterations.Keywords
All Related Versions
Funding Information
- Gouvernement du Canada | Canadian Institutes of Health Research (PJT-148691)
- CCS | Canadian Cancer Society Research Institute (705045)
This publication has 45 references indexed in Scilit:
- Unique functions of CHK1 and WEE1 underlie synergistic anti-tumor activity upon pharmacologic inhibitionCancer Cell International, 2012
- Characterization of the Tumor-Microenvironment in Patient-Derived Cervix Xenografts (OCICx)Cancers, 2012
- The MuvB complex sequentially recruits B-Myb and FoxM1 to promote mitotic gene expressionGenes & Development, 2012
- Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumorsNature Structural & Molecular Biology, 2011
- WEE1 Kinase Targeting Combined with DNA-Damaging Cancer Therapy Catalyzes Mitotic CatastropheClinical Cancer Research, 2011
- A cell-based screen identifies ATR inhibitors with synthetic lethal properties for cancer-associated mutationsNature Structural & Molecular Biology, 2011
- MK-1775, a Potent Wee1 Inhibitor, Synergizes with Gemcitabine to Achieve Tumor Regressions, Selectively in p53-Deficient Pancreatic Cancer XenograftsClinical Cancer Research, 2011
- CHK1 phosphorylates CDC25B during the cell cycle in the absence of DNA damageJournal of Cell Science, 2006
- Sensing DNA Damage Through ATRIP Recognition of RPA-ssDNA ComplexesScience, 2003
- Myt1: A Membrane-Associated Inhibitory Kinase That Phosphorylates Cdc2 on Both Threonine-14 and Tyrosine-15Science, 1995